-
Messi and Alcaraz love it, now padel takes step closer to Olympics
-
Pope arrives in French border city to speak on united Europe
-
Tolls mount in Thailand, Myanmar floods
-
The wildfires choking Indonesia, sparking regional haze
-
Why India's opposition wants top poll official out
-
PU Prime Deepens Argentina Presence Through FX Expo Buenos Aires 2026
-
PU Prime Strengthens UAE Momentum with Strong Showing at Forex Expo Dubai 2026
-
Nothing to seal here: NZ police help stranded pup home
-
Eight dead in Thailand floods since mid-September
-
White House releases list of products US, China could tax less
-
Oil prices spike after Trump rejects Iran truce offer
-
'Pseudo-journalism': Partisan 'news' sites target US midterms
-
Taylor Swift sets new record at MTV VMAs
-
'Currently impossible': North Korea defections in freefall
-
Seoul seeks apology after Ukraine reveals transfer of North Korean POWs
-
Erasmus sizes up 'improved' Wallabies ahead of 2027 World Cup
-
Messi on target again but Miami downed by Columbus
-
Scandal-weary Brazilians to vote as Lula faces Bolsonaro son
-
In Washington's political cauldron, a fight over foie gras
-
SpaceX aims to put Starship in orbit for the first time
-
Flavio Bolsonaro: political heir in his father's shadow
-
Pope to speak on united Europe from French border town
-
Ravens grab last-second win in Rio as Commanders stop Seahawks
-
Scheffler makes sportsmanship stand over tee screamer
-
USA rallies to capture 11th consecutive Presidents Cup
-
Anthropic CEO Amodei to dine with Trump at White House
-
Phillies clinch, Astros wrap up division on final day of MLB season
-
Dupont scores twice to send Toulouse to Top 14 summit
-
Commanders hand champion Seahawks their first loss
-
Greece stun Klopp's Germany as Ireland show sorrow for Gaza
-
Dupont scores twice to send Toulouse top of Top 14
-
Ramos fires holders Portugal to Nations League win in Norway
-
Ireland beat Israel but no handshakes due to war in Gaza
-
Greece hand Klopp first defeat as Germany manager
-
Tense standoff over flashpoint N.Ireland parade lasts into night
-
Pope promises French sex abuse victims to prevent further harm
-
Stunned McNulty wins 'miracle' road race world title
-
UK village on edge over threats to air base in terror alert
-
Re-released 'Avengers: Endgame' snaps-up N. America box office lead
-
Two giant pandas, emblems of China soft diplomacy, arrive in US
-
American McNulty wins shock road race world title
-
Aleksandar Vucic: from Milosevic minister to long-serving Serbian statesman
-
Serbia's President Aleksandar Vucic announces resignation
-
Trump expects new Iran talks despite rejecting deal offer
-
Tuchel urges Bellingham to play with 'rage'
-
Xavi gets first win as Netherlands boss, Denmark beat Wales
-
Russian strikes on Ukraine kill 8
-
Madrid housing protest camp enters second night as PM vows action
-
Bavuma, Miller hit centuries as South Africa clinch series
-
Tigray TV station hit by drone, rebels advance in north Ethiopia
Who should get paid for nature's sequenced genes?
Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.
The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.
Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.
"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.
"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.
Much of the information comes from poor countries.
Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.
At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).
Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?
- 'Cheap and very fast' -
The issue is a complex one.
There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.
But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?
"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.
These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.
DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.
"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.
"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.
- Mandatory -
A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.
They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.
"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.
Another sticking point is access for Indigenous people and local communities to DSI funds.
Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.
But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.
With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.
The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.
Added Barber: "I think it's not going to all get solved here."
I.Meyer--BTB